| __timestamp | Dr. Reddy's Laboratories Limited | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 9086000000 |
| Thursday, January 1, 2015 | 17449000000 | 8935000000 |
| Friday, January 1, 2016 | 17834000000 | 9039000000 |
| Sunday, January 1, 2017 | 19551000000 | 8972000000 |
| Monday, January 1, 2018 | 18265000000 | 9074000000 |
| Tuesday, January 1, 2019 | 15607000000 | 9402000000 |
| Wednesday, January 1, 2020 | 15410000000 | 8980000000 |
| Friday, January 1, 2021 | 16541000000 | 9540000000 |
| Saturday, January 1, 2022 | 17482000000 | 9996000000 |
| Sunday, January 1, 2023 | 19381000000 | 11371000000 |
| Monday, January 1, 2024 | 22873000000 | 10022000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) are the lifeblood of innovation. Over the past decade, Dr. Reddy's Laboratories Limited and Novartis AG have demonstrated their commitment to advancing medical science through substantial R&D investments. From 2014 to 2023, Dr. Reddy's Laboratories consistently increased its R&D spending, peaking in 2024 with a remarkable 84% growth from its 2014 levels. Meanwhile, Novartis AG maintained a steady investment, with a notable 25% increase in 2023 compared to 2014. This strategic focus on R&D underscores the companies' dedication to pioneering new treatments and therapies. However, data for Novartis in 2024 is missing, leaving room for speculation on its future trajectory. As these industry giants continue to innovate, their R&D efforts will likely shape the future of healthcare globally.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Novartis AG
Analyzing R&D Budgets: Novo Nordisk A/S vs Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Novartis AG vs Amneal Pharmaceuticals, Inc.
R&D Insights: How Novartis AG and MannKind Corporation Allocate Funds
R&D Insights: How Genmab A/S and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Madrigal Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Evotec SE